Galantamine Treatment for Nonfluent Aphasia in Stroke Patients

Completed

Phase N/A Results N/A

Summary of Purpose

Cognitive impairment after stroke is common and has a major effect on morbidity and quality of life. Acetylcholinesterase inhibitors have demonstrated benefit in vascular dementia, but efficacy in treating more circumscribed cognitive deficits following stroke, such as aphasia, has not been systematically investigated. This study evaluated the efficacy of Galantamine (Reminyl) in subjects with chronic, stable ...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 May 2010.

1 Oct 2004 21 May 2010 1 Dec 2007 1 Dec 2007 1 May 2010 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Crossover Assignment

Contacts

Not available